Comment on: "Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile: an updated systematic review and meta-analysis".
Minerva Urol Nephrol
; 74(3): 360-362, 2022 06.
Article
in En
| MEDLINE
| ID: mdl-35607782
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms, Castration-Resistant
/
Antineoplastic Agents
Type of study:
Systematic_reviews
Limits:
Humans
/
Male
Language:
En
Journal:
Minerva Urol Nephrol
Year:
2022
Document type:
Article
Affiliation country:
Italy